Israel Cancer Association Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00306020
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Israel Cancer Association

Active Ingredients

Drugs in Phase 4 Trials (1)

hemopoietic stem cell (1 trial)

Drugs in Phase 2 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Drugs in Other Trials (1)

morphine (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3